These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28544032)

  • 41. A systematic review and meta-analysis of deferiprone monotherapy and in combination with deferoxamine for reduction of iron overload in chronically transfused patients with β-thalassemia.
    Kuo KH; Mrkobrada M
    Hemoglobin; 2014; 38(6):409-21. PubMed ID: 25307964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of deferiprone in patients with β-thalassaemia: impact of splenectomy and iron status.
    Limenta LM; Jirasomprasert T; Jittangprasert P; Wilairat P; Yamanont P; Chantharaksri U; Fucharoen S; Morales NP
    Clin Pharmacokinet; 2011 Jan; 50(1):41-50. PubMed ID: 21028920
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
    Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
    J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation between plasma biochemical parameters and cardio-hepatic iron deposition in thalassemia major patients.
    Saadatifar H; Mard-Soltani M; Niayeshfar A; Shakerian N; Pouriamehr S; Alinezhad Dezfuli D; Khalili S; Saadatifar S; Mashhadi SM
    Scand J Clin Lab Invest; 2024 Jul; 84(4):245-251. PubMed ID: 38953608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduction of body iron stores to normal range levels in thalassaemia by using a deferiprone/deferoxamine combination and their maintenance thereafter by deferiprone monotherapy.
    Kolnagou A; Kleanthous M; Kontoghiorghes GJ
    Eur J Haematol; 2010 Nov; 85(5):430-8. PubMed ID: 20662901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel.
    Shalitin S; Abrahami M; Lilos P; Phillip M
    Int J Obes (Lond); 2005 Jun; 29(6):571-8. PubMed ID: 15889115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation of iron overload and glomerular filtration rate estimated by cystatin C in patients with β-thalassemia major.
    Al-Khabori M; Bhandari S; Al-Rasadi K; Mevada S; Al-Dhuhli H; Al-Kemyani N; Daar S
    Hemoglobin; 2014; 38(5):365-8. PubMed ID: 25074643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gender difference in type 2 diabetes and the role of body iron stores.
    Aregbesola A; Voutilainen S; Virtanen JK; Mursu J; Tuomainen TP
    Ann Clin Biochem; 2017 Jan; 54(1):113-120. PubMed ID: 27166309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical Pharmacist-Provided Services In Iron-Overloaded Beta-Thalassaemia Major Children: A New Insight Into Patient Care.
    Bahnasawy SM; El Wakeel LM; Beblawy NE; El-Hamamsy M
    Basic Clin Pharmacol Toxicol; 2017 Apr; 120(4):354-359. PubMed ID: 27800664
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Five Years of Deferasirox Therapy for Cardiac Iron in β-Thalassemia Major.
    Vlachaki E; Agapidou A; Spanos G; Klonizakis P; Vetsiou E; Mavroudi M; Boura P
    Hemoglobin; 2015; 39(5):299-304. PubMed ID: 26177199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic modifiers of secondary iron overload in beta thalassemia major.
    Athiyarath R; George B; Abraham A; Viswabandya A; Srivastava A; Edison ES
    Blood Cells Mol Dis; 2015 Mar; 54(3):242-3. PubMed ID: 25601433
    [No Abstract]   [Full Text] [Related]  

  • 52. Coenzyme Q10 levels in β-thalassemia and its association with ferritin levels and chelation therapy.
    Karakukcu C; Karakukcu M; Unal E; Patiroglu T; Ozdemir MA; Torun YA; Tang PH
    Hemoglobin; 2012; 36(3):219-29. PubMed ID: 22483337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association.
    Pennell DJ; Udelson JE; Arai AE; Bozkurt B; Cohen AR; Galanello R; Hoffman TM; Kiernan MS; Lerakis S; Piga A; Porter JB; Walker JM; Wood J;
    Circulation; 2013 Jul; 128(3):281-308. PubMed ID: 23775258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness of deferiprone in transfusion-independent beta-thalassemia/HbE patients.
    Akrawinthawong K; Chaowalit N; Chatuparisuth T; Siritanaratkul N
    Hematology; 2011 Mar; 16(2):113-22. PubMed ID: 21418744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pattern of iron chelation therapy in Egyptian beta thalassemic patients: Mansoura University Children's Hospital experience.
    Abdelrazik N
    Hematology; 2007 Dec; 12(6):577-85. PubMed ID: 17852442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of hepcidin level with insulin resistance and endocrine glands function in major thalassemia.
    Al-Hakeim HK; Al-Khakani MM; Al-Kindi MA
    Adv Clin Exp Med; 2015; 24(1):69-78. PubMed ID: 25923089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pulmonary dysfunction in thalassaemia major: is there any relationship with body iron stores?
    Guidotti F; Piatti G; Marcon A; Cassinerio E; Giuditta M; Roghi A; Fasano V; Consonni D; Cappellini MD
    Br J Haematol; 2017 Jan; 176(2):309-314. PubMed ID: 27766631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heart Rate Variability for Early Detection of Iron Overload Cardiomyopathy in β-Thalassemia Patients.
    Koonrungsesomboon N; Tantiworawit A; Phrommintikul A; Saekho S; Srichairattanakool S; Chattipakorn N
    Hemoglobin; 2015; 39(4):281-6. PubMed ID: 26029793
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glucose metabolism disorders improvement in patients with thalassaemia major after 24-36 months of intensive chelation therapy.
    Platis O; Anagnostopoulos G; Farmaki K; Posantzis M; Gotsis E; Tolis G
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():279-81. PubMed ID: 16462711
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Zinc supplementation improves glucose homeostasis in patients with β-thalassemia major complicated with diabetes mellitus: A randomized controlled trial.
    Matter RM; Elbarbary NS; Ismail EAR; Darwish YW; Nada AS; Banoub VP
    Nutrition; 2020 May; 73():110702. PubMed ID: 32007694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.